StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)

Close on Nov 17, 2026Market cap $792.02MP/E –Yield –

Lexicon Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lexicon Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -147.4%. For fiscal 2025 it was -101.1%, against -644.8% the year before. The highest annual figure on record is 40.4% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-101.1%+543.7
FY2024Dec 31, 2024-644.8%+14066.1
FY2023Dec 31, 2023-14710.9%+58630.1
FY2022Dec 31, 2022-73341.0%−43892.0
FY2021Dec 31, 2021-29449.0%−29204.9
FY2020Dec 31, 2020-244.1%−284.5
FY2019Dec 31, 201940.4%+231.1
FY2018Dec 31, 2018-190.7%−56.6
FY2017Dec 31, 2017-134.1%+31.7
FY2016Dec 31, 2016-165.8%−162.2
FY2015Dec 31, 2015-3.6%+435.2
FY2014Dec 31, 2014-438.8%+4247.3
FY2013Dec 31, 2013-4686.1%+5434.2
FY2012Dec 31, 2012-10120.4%−3835.1
FY2011Dec 31, 2011-6285.3%−4211.6
FY2010Dec 31, 2010-2073.7%−1300.0
FY2009Dec 31, 2009-773.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-4591.8%−4603.0
Q1 FY2026Mar 31, 2026-4.9%+1999.4
Q4 FY2025Dec 31, 2025-282.7%−155.6
Q3 FY2025Sep 30, 2025-90.0%+3613.4
Q2 FY2025Jun 30, 202511.3%+3255.3
Q1 FY2025Mar 31, 2025-2004.4%+2278.6
Q4 FY2024Dec 31, 2024-127.2%+6960.6
Q3 FY2024Sep 30, 2024-3703.5%+27484.8
Q2 FY2024Jun 30, 2024-3244.0%+10921.3
Q1 FY2024Mar 31, 2024-4282.9%+128775.4
Q4 FY2023Dec 31, 2023-7087.7%+101819.4
Q3 FY2023Sep 30, 2023-31188.3%+28778.4
Q2 FY2023Jun 30, 2023-14165.3%+56083.3
Q1 FY2023Mar 31, 2023-133058.3%+49877.4
Q4 FY2022Dec 31, 2022-108907.1%−8376.7
Q3 FY2022Sep 30, 2022-59966.7%−52245.7
Q2 FY2022Jun 30, 2022-70248.6%+7373.7
Q4 FY2021Dec 31, 2021-182935.7%−180174.4
Q3 FY2021Sep 30, 2021-100530.4%−101775.6
Q2 FY2021Jun 30, 2021-7720.9%−6967.1
Q1 FY2021Mar 31, 2021-77622.2%−76789.5
Q4 FY2020Dec 31, 2020-2761.3%−2175.3
Q3 FY2020Sep 30, 20201245.1%+1168.4
Q2 FY2020Jun 30, 2020-753.8%−516.1
Q1 FY2020Mar 31, 2020-832.7%−596.2
Q4 FY2019Dec 31, 2019-586.0%−487.7
Q3 FY2019Sep 30, 201976.8%+470.1
Q2 FY2019Jun 30, 2019-237.7%+12.7
Q1 FY2019Mar 31, 2019-236.5%−71.7
Q4 FY2018Dec 31, 2018-98.3%−20.0
Q3 FY2018Sep 30, 2018-393.3%−285.6
Q2 FY2018Jun 30, 2018-250.4%+36.3
Q1 FY2018Mar 31, 2018-164.8%+12.9
Q4 FY2017Dec 31, 2017-78.3%+62.4
Q3 FY2017Sep 30, 2017-107.7%+22.2
Q2 FY2017Jun 30, 2017-286.7%–
Q1 FY2017Mar 31, 2017-177.7%–
Q4 FY2016Dec 31, 2016-140.7%–
Q3 FY2016Sep 30, 2016-129.9%–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?